Guangzhou Shengxin Technology Co., Ltd. – Trademark Portfolio
Entity Type: 16
Guangzhou Shengxin Technology Co., Ltd. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 8 (Hand Tools) — 4 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include QIANYA. The owner is based in Guangzhou.
Room 7C, Ricaixuan, Huating City
368 Tianbei Road, Tianhe District
Guangzhou 510000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guangzhou Shengxin Technology Co., Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Guangzhou Shengxin Technology Co., Ltd. have?
Guangzhou Shengxin Technology Co., Ltd. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned, 1 cancelled.
What trademark classes does Guangzhou Shengxin Technology Co., Ltd. file in?
Guangzhou Shengxin Technology Co., Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 8 (Hand Tools), Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 8 covers hand tools and implements (hand-operated); cutlery; side arms; razors.
What are Guangzhou Shengxin Technology Co., Ltd.'s most well-known trademarks?
Guangzhou Shengxin Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as QIANYA. These are among 1 currently registered trademark in the portfolio.
What is Guangzhou Shengxin Technology Co., Ltd.'s trademark registration success rate?
Guangzhou Shengxin Technology Co., Ltd. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.